Do Not Give Promethazine-DM to a 6-Year-Old
Promethazine-containing products are contraindicated in children under 2 years of age and should not be used for cough in children of any age, including 6-year-olds, due to lack of efficacy and significant safety concerns. 1
Why This Recommendation
FDA Labeling and Safety Concerns
The FDA drug label explicitly states that promethazine is contraindicated for children under 2 years of age and should be used with caution in children 2 years and older 1. While technically not absolutely contraindicated at age 6, the combination of promethazine with dextromethorphan for cough treatment lacks evidence of benefit and carries meaningful risks.
Guideline-Based Evidence Against Use
The 2020 CHEST guidelines provide clear direction:
- Over-the-counter cough medications (including antihistamine-dextromethorphan combinations) should not be prescribed for children with acute cough until proven to make cough less severe or resolve sooner 2
- These preparations are associated with adverse events, including reported deaths from toxicity in young children 2
- Antihistamines (like promethazine) have minimal to no efficacy in relieving cough in children, in contrast to adults 2
Specific Safety Risks
Promethazine-related adverse events include:
- Significant sedation and altered consciousness 3, 4
- Agitation and hallucinations 4
- Seizures and dystonic reactions 4
- Possible apparent life-threatening events 4
- Respiratory depression 1, 5
Dextromethorphan-related adverse events include:
- Altered level of consciousness even at therapeutic doses 3
- Children becoming unresponsive to verbal commands and pain stimuli 3
- More frequent adverse effects at higher doses 6
Research Evidence Shows No Benefit
A randomized controlled trial directly comparing promethazine, dextromethorphan, and placebo in children aged 1-12 years with upper respiratory infections found no superior benefit for either active medication compared to placebo for nocturnal cough severity, post-tussive vomiting, or sleep quality 7. The entire cohort improved after 3 days regardless of treatment, demonstrating the self-resolving nature of URI-related cough.
What to Use Instead
Honey is the evidence-based alternative for children over 1 year of age:
- Offers more relief than no treatment, diphenhydramine, or placebo 2
- Comparable efficacy to dextromethorphan without the safety concerns 2
For children under 1 year: Supportive care only (honey is contraindicated due to botulism risk)
Clinical Pitfalls to Avoid
Don't assume OTC status implies safety - The ease of administration and perceived safety of syrups leads to inappropriate use, particularly in younger children 4
Don't treat cough symptomatically without identifying etiology - Cough should be treated based on underlying cause, not suppressed reflexively 2
Re-evaluate if symptoms persist - If cough doesn't resolve within 2-4 weeks, reassess for specific etiological pointers rather than continuing ineffective medications 2
Recognize self-resolution - Most childhood cough from URI improves spontaneously within days, making any medication appear effective when it's actually the natural disease course 7